PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet. 2016 Dec;53(12):800-811. doi: 10.1136/jmedgenet-2016
This report adds to accumulating evidence that at least some variants in these genes are associated with an increased risk of breast cancer that is clinically ...
The rarity of mutations in PALB2, CHEK2 and ATM make it difficult to estimate precisely associated cancer risks. Population-based family studies have provided ...
Background: The rarity of mutations in PALB2, CHEK2 and ATM make it difficult to estimate precisely associated cancer risks. Population-based family studies ...
BackgroundThe rarity of mutations in PALB2, CHEK2 and ATM make it difficult to estimate precisely associated cancer risks. Population-based family studies ...
RESULTS: For European women, strong evidence of association with breast cancer risk was observed for PALB2 c.1592delT OR 3.44 (95% CI 1.39 to 8.52, p=7.1×10-5), ...
Background. The rarity of mutations in PALB2, CHEK2 and ATM make it difficult to estimate precisely associated cancer risks. Population-based family studies ...
Sep 5, 2016 · We aimed to estimate the relative risks associated with specific rare variants in PALB2, CHEK2 and ATM via a multicentre case-control study.
We aimed to estimate the relative risks associated with specific rare variants in PALB2, CHEK2 and ATM via a multicentre case-control study. Methods: We ...
People also ask
What is the risk of getting cancer with the PALB2 gene mutation?
How serious is the CHEK2 mutation?
How often should you have a colonoscopy with a CHEK2 mutation?
What does it mean when you are PALB2 positive?
Jun 28, 2016 · We aimed to estimate the relative risks associated with specific rare variants in PALB2, CHEK2 and ATM via a multi-centre case-control study.
